Treatment of brain metastases: Chemotherapy

Current Oncology Reports

Volumn 14, Issue 1, 2012, Pages 85-90

  Grimm, Sean A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Brain metastases; Chemotherapy; Corticosteroids; Neuro oncology; Supportive care

Indexed keywords

ANTHRACYCLINE; BEVACIZUMAB; CANCER VACCINE; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ERLOTINIB; ETIRACETAM; ETOPOSIDE; FLUOROURACIL; FOTEMUSTINE; GABAPENTIN; GADOLINIUM TEXAPHYRIN; HARKOSERIDE; IPILIMUMAB; LAMOTRIGINE; LAPATINIB; METHOTREXATE; SORAFENIB; SUNITINIB; TEMOZOLOMIDE; TIAGABINE; TOPIRAMATE; TOPOTECAN; TRASTUZUMAB; UNINDEXED DRUG; VALPROIC ACID; VORINOSTAT; ZONISAMIDE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; GLIOBLASTOMA; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; MOLECULARLY TARGETED THERAPY; OVERALL SURVIVAL; SEIZURE; SYSTEMIC THERAPY; TREATMENT RESPONSE; TUMOR VOLUME; WHOLE BRAIN RADIATION THERAPY;

ADRENAL CORTEX HORMONES; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; DRUG INTERACTIONS; HUMANS;

EID: 84857627477     PISSN: 15233790     EISSN: 15346269     Source Type: Journal    
DOI: 10.1007/s11912-011-0211-y     Document Type: Article

References (49)

1. MP Mehta NA Paleologos T Mikkelsen, et al. 2010 The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline J Neurooncol 96 1 71 83 19960229 10.1007/s11060-009-0062-7
2. DeAngelis LM, Posner JB, Posner JB. Neurologic complications of cancer. 2nd ed. Oxford, New York: Oxford University Press; 2009. xv, 634 p.
3. AF Eichler E Chung DP Kodack, et al. 2011 The biology of brain metastases-translation to new therapies Nat Rev Clin Oncol 8 6 344 56 21487419 1:CAS:528:DC%2BC3MXmvFOgtr8%3D
4. ER Gerstner RL Fine 2007 Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm J Clin Oncol 25 16 2306 12 17538177 10.1200/JCO.2006.10.0677 (Pubitemid 46954659)
5. IJ Fidler 2011 The role of the organ microenvironment in brain metastasis Semin Cancer Biol 21 2 107 12 21167939 10.1016/j.semcancer.2010.12.009
6. RL Fine J Chen C Balmaceda, et al. 2006 Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors Clin Cancer Res 12 19 5770 6 17020983 10.1158/1078-0432.CCR-05-2356 1:CAS:528:DC%2BD28XhtVartbvE (Pubitemid 44629608)
7. FG Kamar JB Posner 2004 Brain metastases Semin Neurol 30 3 217 35 10.1055/s-0030-1255225
8. KY Yap WK Chui A Chan 2008 Drug interactions between chemotherapeutic regimens and antiepileptics Clin Ther 30 8 1385 407 18803983 10.1016/j.clinthera.2008.08.011 1:CAS:528:DC%2BD1cXhtF2rtLfI
9. CJ Vecht M van Breemen 2006 Optimizing therapy of seizures in patients with brain tumors Neurology 67 12 Suppl 4 S10 3 17190914
10. JS Barnholtz-Sloan AE Sloan FG Davis, et al. 2004 Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System J Clin Oncol 22 14 2865 72 15254054 10.1200/JCO.2004.12.149 (Pubitemid 41079905)
11. ES Nussbaum HR Djalilian KH Cho, et al. 1996 Brain metastases. Histology, multiplicity, surgery, and survival Cancer 78 8 1781 8 8859192 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U 1:STN:280:DyaK2s%2Fht1ektQ%3D%3D (Pubitemid 26330907)
12. LJ Schouten J Rutten HA Huveneers, et al. 2002 Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma Cancer 94 10 2698 705 12173339 10.1002/cncr.10541 (Pubitemid 34478086)
13. CJ Langer MP Mehta 2005 Current management of brain metastases, with a focus on systemic options J Clin Oncol 23 25 6207 19 16135488 10.1200/JCO.2005.03.145 1:CAS:528:DC%2BD2MXhtVKgtbrP
14. A Forouzannia GM Richards D Khuntia, et al. 2007 Motexafin gadolinium: a novel radiosensitizer for brain tumors Expert Rev Anticancer Ther 7 6 785 94 17555388 10.1586/14737140.7.6.785 1:CAS:528:DC%2BD2sXmtFOhtbk%3D (Pubitemid 47007985)
15. MP Mehta WR Shapiro SC Phan, et al. 2009 Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Int J Radiat Oncol Biol Phys 73 4 1069 76 18977094 10.1016/j.ijrobp.2008.05.068 1:CAS:528:DC%2BD1MXisVOgsb8%3D
16. R Stupp WP Mason MJ van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 987 96 15758009 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D (Pubitemid 40349501)
17. A Chakravarti MG Erkkinen U Nestler, et al. 2006 Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms Clin Cancer Res 12 15 4738 46 16899625 10.1158/1078-0432.CCR-06-0596 1:CAS:528:DC%2BD28XnvVGksLc%3D (Pubitemid 44297828)
18. WJ Kil D Cerna WE Burgan, et al. 2008 In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide Clin Cancer Res 14 3 931 8 18245557 10.1158/1078-0432.CCR-07-1856 1:CAS:528: DC%2BD1cXhsFyktb4%3D (Pubitemid 351231178)
19. D Antonadou M Paraskevaidis G Sarris, et al. 2002 Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 20 17 3644 50 12202665 10.1200/JCO.2002.04.140 1:CAS:528:DC%2BD38XntVynsrk%3D (Pubitemid 34983224)
20. CMA Dardoufas C Skareleas, et al. 2001 Concomitant temozolomide and radiotherapy followed by adjuvant treatment with temozolomide in patients with brain metastases from solid tumors Proc Am Soc Clin Oncol 20 75b
21. E Verger M Gil R Yaya, et al. 2005 Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial Int J Radiat Oncol Biol Phys 61 1 185 91 15629610 10.1016/j.ijrobp.2004. 04.061 1:CAS:528:DC%2BD2MXjsVCr (Pubitemid 40039121)
22. MA Socinski CJ Langer JE Huang, et al. 2009 Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases J Clin Oncol 27 31 5255 61 19738122 10.1200/JCO.2009.22.0616 1:CAS:528:DC%2BD1MXhsFahsLjL
23. KC De Braganca YY Janjigian CG Azzoli, et al. 2010 Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer J Neurooncol 100 3 443 7 20440540 10.1007/s11060-010-0200-2
24. B Weber M Winterdahl A Memon, et al. 2011 Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor J Thorac Oncol 6 7 1287 9 21847041 10.1097/JTO.0b013e318219ab87
25. R Porta JM Sanchez-Torres L Paz-Ares, et al. 2011 Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation Eur Respir J 37 3 624 31 20595147 10.1183/09031936.00195609 1:CAS:528:DC%2BC3MXmslemtLo%3D
26. Grommes C, Oxnard GR, Kris MG et al. "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer. Neuro Oncol 2011.
27. Barlesi F, Gervais R, Lena H et al. Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01). Ann Oncol 2011.
28. NU Lin JR Bellon EP Winer 2004 CNS metastases in breast cancer J Clin Oncol 22 17 3608 17 15337811 10.1200/JCO.2004.01.175 (Pubitemid 41103668)
29. C Arslan O Dizdar K Altundag 2010 Systemic treatment in breast-cancer patients with brain metastasis Expert Opin Pharmacother 11 7 1089 100 20345334 10.1517/14656561003702412 1:CAS:528:DC%2BC3cXntVyqt70%3D
30. W Boogerd O Dalesio EM Bais, et al. 1992 Response of brain metastases from breast cancer to systemic chemotherapy Cancer 69 4 972 80 1735089 10.1002/1097-0142(19920215)69:4<972::AID-CNCR2820690423>3.0.CO;2-P 1:STN:280:DyaK387js1ensA%3D%3D
31. D Rosner T Nemoto WW Lane 1986 Chemotherapy induces regression of brain metastases in breast carcinoma Cancer 58 4 832 9 3755076 10.1002/1097- 0142(19860815)58:4<832::AID-CNCR2820580404>3.0.CO;2-W 1:STN:280: DyaL283ksVOjtg%3D%3D (Pubitemid 16035278)
32. M Ekenel AM Hormigo S Peak, et al. 2007 Capecitabine therapy of central nervous system metastases from breast cancer J Neurooncol 85 2 223 7 17611719 10.1007/s11060-007-9409-0 1:CAS:528:DC%2BD2sXhtl2gs7rI (Pubitemid 47629405)
33. A Fabi A Vidiri G Ferretti, et al. 2006 Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow? Cancer Invest 24 4 466 8 16777702 10.1080/07357900600705805 1:STN:280:DC%2BD28zmtlWrtA%3D%3D (Pubitemid 43932692)
34. ML Wang WK Yung ME Royce, et al. 2001 Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer Am J Clin Oncol 24 4 421 4 11474279 10.1097/00000421-200108000-00026 1:STN:280: DC%2BD3MvislShsw%3D%3D (Pubitemid 32730746)
35. EA Lien K Wester PE Lonning, et al. 1991 Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients Br J Cancer 63 4 641 5 2021551 10.1038/bjc.1991.147 1:STN:280:DyaK3M3hsVygtg%3D%3D
36. H Pors FE von Eyben OS Sorensen, et al. 1991 Longterm remission of multiple brain metastases with tamoxifen J Neurooncol 10 2 173 7 1716670 10.1007/BF00146879 1:STN:280:DyaK3MznsVWqug%3D%3D
37. M Salvati L Cervoni G Innocenzi, et al. 1993 Prolonged stabilization of multiple and single brain metastases from breast cancer with tamoxifen. Report of three cases Tumori 79 5 359 62 8116083 1:STN:280:DyaK2c7mtVertA%3D%3D (Pubitemid 24098940)
38. DJ Stewart S Dahrouge 1995 Response of brain metastases from breast cancer to megestrol acetate: a case report J Neurooncol 24 3 299 301 7595761 10.1007/BF01052847 1:STN:280:DyaK28%2FovVGitw%3D%3D
39. OP Kallioniemi K Holli T Visakorpi, et al. 1991 Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer Int J Cancer 49 5 650 5 1682277 10.1002/ijc.2910490504 1:STN:280:DyaK38%2FktVelsQ%3D%3D
40. NU Lin EP Winer 2007 Brain metastases: the HER2 paradigm Clin Cancer Res 13 6 1648 55 17363517 10.1158/1078-0432.CCR-06-2478 1:CAS:528: DC%2BD2sXivV2gtro%3D (Pubitemid 46952930)
41. IB Fuchs M Loebbecke H Buhler, et al. 2002 HER2 in brain metastases: issues of concordance, survival, and treatment J Clin Oncol 20 19 4130 3 12351617 10.1200/JCO.2002.04.016
42. NU Lin V Dieras D Paul, et al. 2009 Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer Clin Cancer Res 15 4 1452 9 19228746 10.1158/1078-0432.CCR-08-1080 1:CAS:528:DC%2BD1MXitVOktLo%3D
43. Lin NU, Eierman W, Greil R et al. Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. J Neurooncol 2011.
44. A Tarhini E Lo DR Minor 2010 Releasing the brake on the immune system: ipilimumab in melanoma and other tumors Cancer Biother Radiopharm 25 6 601 13 21204754 10.1089/cbr.2010.0865 1:CAS:528:DC%2BC3MXht1ygsA%3D%3D
45. DPHO Lawrence DF McDermott, et al. 2010 Phase II trial of ipilimumamb monotherapy in melanoma patients with brain metastases J Clin Oncol 28 suppl 7s8523
46. ME Gore S Hariharan C Porta, et al. 2011 Sunitinib in metastatic renal cell carcinoma patients with brain metastases Cancer 117 3 501 9 20862748 10.1002/cncr.25452 1:CAS:528:DC%2BC3MXitFKitL8%3D
47. WM Stadler RA Figlin DF McDermott, et al. 2010 Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America Cancer 116 5 1272 80 20082451 10.1002/cncr.24864 1:CAS:528:DC%2BC3cXjs1GrtLg%3D
48. KL Hill Jr AC Lipson JM Sheehan 2009 Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma J Neurosurg 111 3 497 503 19199506 10.3171/2008.7.JNS08143
49. PJ Kelly SE Weiss DJ Sher, et al. 2010 Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma J Clin Oncol 28 25 e433 5 20547999 10.1200/JCO.2009.26.8193